Related Experiment Video
Updated: Mar 12, 2026

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
Published on: July 31, 2017
Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder
Jeanne M Madden1,2, Matthew D Lakoma3, Frances L Lynch4
1Department of Pharmacy and Health Systems Sciences, School of Pharmacy, Bouvé College of Health Sciences, Northeastern University, 360 Huntington Avenue R218X TF, Boston, MA, 02115, USA. j.madden@northeastern.edu.
Insights
Nearly half of children with autism spectrum disorder (ASD) use psychotropic medications, significantly more than their peers. This highlights treatment challenges and the need for more research on medication effectiveness in ASD.
Area of Science:
- Pediatric Psychiatry
- Neurodevelopmental Disorders
- Pharmacology
Background:
- Autism spectrum disorder (ASD) is a complex neurodevelopmental condition.
- Psychotropic medication use in children with ASD is a growing concern.
- Limited evidence exists for the efficacy of many psychotropic medications in pediatric ASD populations.
Purpose of the Study:
- To examine the prevalence of psychotropic medication use in children with ASD.
- To compare psychotropic medication use in children with ASD to matched controls without ASD.
- To identify common classes of psychotropic medications prescribed to children with ASD.
Main Methods:
- Retrospective cohort study involving 7901 children aged 1-17 with ASD.
- Comparison with matched cohorts of children without ASD across five health systems.
- Analysis of psychotropic medication classes including stimulants, alpha-agonists, atomoxetine, antipsychotics, and antidepressants.
Main Results:
- 48.5% of children with ASD received psychotropic medications.
- Psychotropic use was significantly higher in children with ASD (48.5%) compared to controls (7.7%).
- Commonly prescribed classes were stimulants/alpha-agonists/atomoxetine (30.2%), antipsychotics (20.5%), and antidepressants (17.8%).
Conclusions:
- Psychotropic medication use is highly prevalent in children with ASD.
- Disparities in psychotropic use exist between children with and without ASD, even when controlling for other psychiatric diagnoses.
- The findings underscore the need for improved evaluation and evidence-based treatment strategies for ASD.
Abstract:
This study examined psychotropic medication use among 7901 children aged 1-17 with autism spectrum disorder (ASD) in five health systems, comparing to matched cohorts with no ASD. Nearly half (48.5 %) of children with ASD received psychotropics in the year observed; the most common classes were stimulants, alpha-agonists, or atomoxetine (30.2 %), antipsychotics (20.5 %), and antidepressants (17.8 %). Psychotropic treatment was far more prevalent among children with ASD, as compared to children with no ASD (7.7 % overall), even within strata defined by the presence or absence of other psychiatric diagnoses. The widespread use of psychotropics we observed, particularly given weak evidence supporting the effectiveness of these medications for most children with ASD, highlights challenges in ASD treatment and the need for greater investment in its evaluation.
More Related Videos
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Psychosis: Goals of Pharmacotherapy

